Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Dyrda

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Gastroenterology & Hepatology|June 13, 2015
Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management surveySteve Kanters, Kristian Thorlund, Kuhan Perampaladas, et al.
Current Medical Research and Opinion|February 8, 2019
Treatment sequence network meta-analysis in Crohn's disease: a methodological case studyAbhishek Varu, Florence R Wilson, Peter Dyrda, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2017
The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative ColitisChris Cameron, Emmanuel Ewara, Florence R Wilson, et al.
Managed Care (Langhorne, Pa.)|March 9, 2017
BioAdvance Patient Support Program Survey: Positive Perception of Intravenous Infusions of InfliximabJennifer Jones, Mark Borgaonkar, Jesse Siffledeen, et al.
Arthritis Care & Research|September 18, 2018
Patient Perspectives on Intravenous Biologics for Rheumatologic DiseaseLucas Grisanti, Alysia Kwiatkowski, Peter Dyrda, et al.
The Journal of Physiology|March 28, 2012
Mechanisms of VIP-induced inhibition of the lymphatic vessel pumpPierre-Yves von der Weid, Sonia Rehal, Peter Dyrda, et al.
American Journal of Respiratory Cell and Molecular Biology|April 17, 2010
Acute response of airway muscle to extreme temperature includes disruption of actin-myosin interactionPeter Dyrda, Tracy Tazzeo, Lindsay DoHarris, et al.
Journal of Medical Economics|August 24, 2017
Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulationSean Stern, Alexandra J Ward, Catherine Saint-Laurent Thibault, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Gastroenterology & Hepatology|June 13, 2015
Factors associated with changes in self-reported health status in infliximab-treated inflammatory bowel disease patients: results from a case management surveySteve Kanters, Kristian Thorlund, Kuhan Perampaladas, et al.
Current Medical Research and Opinion|February 8, 2019
Treatment sequence network meta-analysis in Crohn's disease: a methodological case studyAbhishek Varu, Florence R Wilson, Peter Dyrda, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2017
The Importance of Considering Differences in Study Design in Network Meta-analysis: An Application Using Anti-Tumor Necrosis Factor Drugs for Ulcerative ColitisChris Cameron, Emmanuel Ewara, Florence R Wilson, et al.
Managed Care (Langhorne, Pa.)|March 9, 2017
BioAdvance Patient Support Program Survey: Positive Perception of Intravenous Infusions of InfliximabJennifer Jones, Mark Borgaonkar, Jesse Siffledeen, et al.
Arthritis Care & Research|September 18, 2018
Patient Perspectives on Intravenous Biologics for Rheumatologic DiseaseLucas Grisanti, Alysia Kwiatkowski, Peter Dyrda, et al.
The Journal of Physiology|March 28, 2012
Mechanisms of VIP-induced inhibition of the lymphatic vessel pumpPierre-Yves von der Weid, Sonia Rehal, Peter Dyrda, et al.
American Journal of Respiratory Cell and Molecular Biology|April 17, 2010
Acute response of airway muscle to extreme temperature includes disruption of actin-myosin interactionPeter Dyrda, Tracy Tazzeo, Lindsay DoHarris, et al.
Journal of Medical Economics|August 24, 2017
Cost-effectiveness of golimumab for the treatment of patients with moderate-to-severe ulcerative colitis in Quebec using a patient level state transition microsimulationSean Stern, Alexandra J Ward, Catherine Saint-Laurent Thibault, et al.
Pageof 1